| scholarly article | Q13442814 |
| P2093 | author name string | John R Wingard | |
| P2860 | cites work | Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever | Q28216366 |
| Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group | Q31372000 | ||
| Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients | Q35819117 | ||
| Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlle | Q40596481 | ||
| Prevention of fungal sepsis in patients with prolonged neutropenia: a randomized, double-blind, placebo-controlled trial of intravenous miconazole | Q40791794 | ||
| Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia | Q40847963 | ||
| Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole | Q43543160 | ||
| A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation | Q43619964 | ||
| Fluconazole to prevent yeast infections in bone marrow transplantation patients: a randomized trial of high versus reduced dose, and determination of the value of maintenance therapy | Q43923731 | ||
| Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. | Q51192216 | ||
| Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. | Q51192827 | ||
| Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study. | Q53999286 | ||
| Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study. | Q54171057 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1386-1390 | |
| P577 | publication date | 2002-04-17 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | Antifungal chemoprophylaxis after blood and marrow transplantation | |
| P478 | volume | 34 |
| Q40517539 | A prospective study of real-time panfungal PCR for the early diagnosis of invasive fungal infection in haemato-oncology patients |
| Q49425859 | Application of Culture-Independent Rapid Diagnostic Tests in the Management of Invasive Candidiasis and Cryptococcosis |
| Q33719294 | Aspergillus infections in transplant recipients |
| Q35833407 | Choices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients |
| Q37323880 | Current trends of infectious complications following hematopoietic stem cell transplantation in a single center |
| Q37859365 | Empiric antifungal therapy in patients with febrile neutropenia |
| Q34490092 | Fluconazole for the management of invasive candidiasis: where do we stand after 15 years? |
| Q34749162 | In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood. |
| Q53636518 | Infectious complications and outcomes after allogeneic hematopoietic stem cell transplantation in Korea. |
| Q40236957 | Oral status of patients submitted to autologous hematopoietic stem cell transplantation |
| Q35912243 | Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. |
Search more.